Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GrassMATAMPL in Patients Sensitized to Grass and Rye Pollen
NCT00133159Phase 2Completed
- Sponsor
- Allergy Therapeutics PLC
- Start
- Sep 2005
- Primary completion
- Nov 2005
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of Grass MATA MPL in seasonal allergic rhinitis (SAR), sponsored by Allergy Therapeutics PLC. Started Sep 2005; status: completed.
02
Drugs
Grass MATA MPL
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00133159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133159.